The HIV-1 viral protein Tat increases glutamate and decreases GABA exocytosis from human and mouse neocortical nerve endings.
about
HIV-associated neurocognitive disorder--pathogenesis and prospects for treatmentRoles and functions of HIV-1 Tat protein in the CNS: an overviewPresynaptic Release-Regulating mGlu1 Receptors in Central Nervous SystemHIV-1 Tat-induced changes in synaptically-driven network activity adapt during prolonged exposure.Glutamate excitotoxicity is involved in the induction of paralysis in mice after infection by a human coronavirus with a single point mutation in its spike protein.The altered expression of α1 and β3 subunits of the gamma-aminobutyric acid A receptor is related to the hepatitis C virus infectionHIV-1 Tat-Mediated Calcium Dysregulation and Neuronal Dysfunction in Vulnerable Brain Regions.Inhibition of GABAergic Neurotransmission by HIV-1 Tat and Opioid Treatment in the Striatum Involves μ-Opioid Receptors.Acute desipramine restores presynaptic cortical defects in murine experimental autoimmune encephalomyelitis by suppressing central CCL5 overproduction.An Overview of Human Immunodeficiency Virus Type 1-Associated Common Neurological Complications: Does Aging Pose a Challenge?HIV, Tat and dopamine transmission.N-(Pivaloyloxy)alkoxy-carbonyl Prodrugs of the Glutamine Antagonist 6-Diazo-5-oxo-l-norleucine (DON) as a Potential Treatment for HIV Associated Neurocognitive Disorders.Chronic Tobacco-Smoking on Psychopathological Symptoms, Impulsivity and Cognitive Deficits in HIV-Infected Individuals.Network Analysis of Hippocampal Neurons by Microelectrode Array in the Presence of HIV-1 Tat and Cocaine.CXCR4 and NMDA Receptors Are Functionally Coupled in Rat Hippocampal Noradrenergic and Glutamatergic Nerve Endings.Presynaptic mGlu1 Receptors Control GABA Receptors in an Antagonist-Like Manner in Mouse Cortical GABAergic and Glutamatergic Nerve Endings
P2860
Q26766448-530644F0-0AB9-409B-9041-04822DDF02B3Q26996314-26187953-8572-430E-B281-B0A9BF1E13C0Q28073858-013B7854-CA54-4383-95E0-3194BFB655BBQ30638542-01DB8632-398C-4BBC-B60C-3B04BD2961ADQ35531623-1D06AAE9-47C4-4B0D-BC7D-0244BA858F87Q35999192-580A76F2-387D-45CB-A021-F2C907F0FDD9Q36634476-9909425A-6CD2-4AD7-9BA0-05F089A8A014Q37399037-E3D98F5C-F116-4D51-B135-7B0631E62396Q37719431-FF7884A7-52F2-4E24-8EA5-CAB96A70E549Q38628801-2A191A76-593D-45EE-B5FE-5A582947B27EQ38812005-006DEB00-4870-493B-8469-BB23B8D52A73Q40113255-A922DE25-5DD2-46E6-B5E3-E0864F7D9684Q40290534-112EC0CA-DBFA-4922-8748-1E821D79A9CDQ47329696-311D746E-47B8-411A-944F-FE74D6837BC9Q48768162-06F4DB19-07C8-4070-ADB9-55BDB74CDD33Q57073759-EC0725D6-0D31-4F85-8353-514E4C047ACF
P2860
The HIV-1 viral protein Tat increases glutamate and decreases GABA exocytosis from human and mouse neocortical nerve endings.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
The HIV-1 viral protein Tat in ...... use neocortical nerve endings.
@en
The HIV-1 viral protein Tat in ...... use neocortical nerve endings.
@nl
type
label
The HIV-1 viral protein Tat in ...... use neocortical nerve endings.
@en
The HIV-1 viral protein Tat in ...... use neocortical nerve endings.
@nl
prefLabel
The HIV-1 viral protein Tat in ...... use neocortical nerve endings.
@en
The HIV-1 viral protein Tat in ...... use neocortical nerve endings.
@nl
P2093
P50
P356
P1433
P1476
The HIV-1 viral protein Tat in ...... ouse neocortical nerve endings
@en
P2093
Anna Pittaluga
Elisa Neri
Maurizio Raiteri
Paolo Severi
Tomasz T Godowicz
Veronica Musante
P304
P356
10.1093/CERCOR/BHP274
P577
2009-12-24T00:00:00Z